ArticleRegenerative therapy2026
Strategies and challenges in developing pre-vascularized three-dimensional skin substitutes using layer-by-layer cell coating technology.
Article in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Irreversible cutaneous injuries must be treated by skin transplantation. Autologous skin grafts are the gold standard; however, donor sites are often limited in patients with extensive injuries. Conventional artificial skin substitutes are also effective in several clinical cases. However, a major limitation is the lack of vascular structures, which results in delayed perfusion, increased risk of infection, and engraftment failure, especially in intractable wounds. To address this challenge, various advanced tissue engineering technologies have been explored to develop novel three-dimensional (3D) skin substitutes with vascular networks. In this review, we first discuss recent progress in the development of tissue-engineered 3D skin models. In particular, we highlight a 3D culture technique based on the layer-by-layer (LbL) method, which forms ultrathin films of extracellular matrix proteins on cell surfaces and promotes the self-assembly of cells. We also describe the developmental history of the LbL method for fabricating 3D biological tissue models, including skin constructs. Furthermore, we introduce our original application of photobiomodulation (PBM), an optical activation method, to LbL-3D skin during cultivation. Finally, we present the results of transplanting LbL-3D skin onto a mouse wound model and discuss the future prospects for this skin substitute.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.